No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs553061832 |
chr3:49586466-49586467 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs148961138 |
chr3:49586496-49586497 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs554690242 |
chr3:49586512-49586513 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs142853520 |
chr3:49586540-49586541 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs146557783 |
chr3:49586542-49586543 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs564850754 |
chr3:49586597-49586598 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs569221710 |
chr3:49586628-49586629 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs554803996 |
chr3:49586661-49586662 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs541306555 |
chr3:49586671-49586672 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs75470186 |
chr3:49586700-49586701 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs529814586 |
chr3:49586829-49586830 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs367712376 |
chr3:49586979-49586980 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs77701561 |
chr3:49586985-49586986 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs548013550 |
chr3:49587026-49587027 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs375773602 |
chr3:49587054-49587055 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs563168314 |
chr3:49587064-49587065 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs200704753 |
chr3:49587074-49587075 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs531650257 |
chr3:49587110-49587111 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs550018017 |
chr3:49587178-49587179 |
Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs571607774 |
chr3:49587202-49587203 |
Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs59579780 |
chr3:49587211-49587212 |
Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs572871097 |
chr3:49587240-49587241 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs193207104 |
chr3:49587393-49587394 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs566279791 |
chr3:49587407-49587408 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs114465719 |
chr3:49587448-49587449 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs555173212 |
chr3:49587463-49587464 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs139009816 |
chr3:49587466-49587467 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs77682947 |
chr3:49587468-49587469 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs369215887 |
chr3:49587527-49587528 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs558408147 |
chr3:49587536-49587537 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs183623920 |
chr3:49587646-49587647 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs540695873 |
chr3:49587653-49587654 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs553214584 |
chr3:49587675-49587676 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs574353654 |
chr3:49587729-49587730 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs541726598 |
chr3:49587752-49587753 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs112108559 |
chr3:49587812-49587813 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs187335718 |
chr3:49587872-49587873 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs530660537 |
chr3:49587877-49587878 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs140694974 |
chr3:49587937-49587938 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs191816303 |
chr3:49587957-49587958 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs183895482 |
chr3:49587983-49587984 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs547439924 |
chr3:49588058-49588059 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs371016925 |
chr3:49588095-49588096 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs35883547 |
chr3:49588109-49588110 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs566101402 |
chr3:49588124-49588125 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs377609188 |
chr3:49588125-49588126 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs115541747 |
chr3:49588138-49588139 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs568277527 |
chr3:49588157-49588158 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs570252062 |
chr3:49588172-49588173 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs150456231 |
chr3:49588189-49588190 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|